Back to Search
Start Over
Inhibition of HUVEC tubulogenesis by hederacolchiside-A1 is associated with plasma membrane cholesterol sequestration and activation of the Ha-Ras/MEK/ERK cascade.
- Source :
-
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2004 Nov; Vol. 54 (5), pp. 432-40. Date of Electronic Publication: 2004 Jul 28. - Publication Year :
- 2004
-
Abstract
- Purpose: Neoangiogenesis is critical to cancer proliferation and metastasis and constitutes an attractive target for cancer therapy. It has previously been demonstrated that hederacolchiside-A1 (HCol-A1), a triterpenoid saponin from Hedera colchica Koch, has antimelanoma potential. The goal of this study was to evaluate, in vitro, if in addition to its tumoricidal effect on melanoma cells, HCol-A1 might affect endothelial cell network formation.<br />Methods: We investigated whether HCol-A1 affects matrigel-induced tubulogenesis and inhibits the viability (WST-1 assay) of human umbilical vein endothelial cells (HUVECs). To provide structure-activity relationships (SAR), studies were conducted on HCol-A1, oleanolic acid and hederacolchiside A (HCol-A), a triterpenoid saponin which possess the same sugar sequence as Hcol-A1. Plasma membrane cholesterol sequestration was studied by labelling with [3H]cholesterol and assayed with HCol-A1-cholesterol complexes. HCol-A1 signalling was investigated using immunoassays.<br />Results: In contrast to HCol-A and oleanolic acid, HCol-A1 inhibited matrigel-induced angiogenesis at micromolar concentration. Plasma membrane cholesterol sequestration was found to be critical for this activity. Activation of the Ras/MEK/ERK cascade appears to be one of the mechanisms by which Hcol-A1 affects HUVEC network formation. The predominant activation of the Ha-Ras isoform, which decreases HUVEC-tolerance to apoptosis, might contribute to the high susceptibility of this cell line to HCol-A1.<br />Conclusion: Since cholesterol sequestration affects cell confluence-dependent remodelling of endothelial membranes and vascular endothelial growth factor receptor-2 activity, these results raise the possibility that Hcol-A1 might slow-down cancer proliferation and metastasis in vivo by inhibiting critical aspects of neoangiogenesis. Further in vivo studies are needed to verify this hypothesis.
- Subjects :
- Cell Survival drug effects
Cholesterol blood
Endothelium, Vascular cytology
Endothelium, Vascular drug effects
Humans
MAP Kinase Signaling System drug effects
Oleanolic Acid pharmacology
Umbilical Veins
Endothelium, Vascular physiology
MAP Kinase Kinase Kinases metabolism
MAP Kinase Signaling System physiology
Neovascularization, Pathologic prevention & control
Saponins pharmacology
p38 Mitogen-Activated Protein Kinases metabolism
ras Proteins metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0344-5704
- Volume :
- 54
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Cancer chemotherapy and pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 15490165
- Full Text :
- https://doi.org/10.1007/s00280-004-0813-2